Atara Biotherapeutics Inc (ATRA)
10.61
-0.07
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
10.60
-0.01
(-0.09%)
After-Hours: 20:00
Atara Biotherapeutics Max Drawdown (5Y): 99.47% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.47% |
| September 30, 2024 | 99.47% |
| August 31, 2024 | 99.47% |
| July 31, 2024 | 99.47% |
| June 30, 2024 | 99.47% |
| May 31, 2024 | 99.47% |
| April 30, 2024 | 99.47% |
| March 31, 2024 | 99.47% |
| February 29, 2024 | 99.47% |
| January 31, 2024 | 99.47% |
| December 31, 2023 | 99.47% |
| November 30, 2023 | 99.47% |
| October 31, 2023 | 97.09% |
| September 30, 2023 | 96.94% |
| August 31, 2023 | 96.94% |
| July 31, 2023 | 96.94% |
| June 30, 2023 | 96.94% |
| May 31, 2023 | 96.88% |
| April 30, 2023 | 95.41% |
| March 31, 2023 | 94.56% |
| February 28, 2023 | 94.46% |
| January 31, 2023 | 94.46% |
| December 31, 2022 | 94.46% |
| November 30, 2022 | 94.46% |
| October 31, 2022 | 94.46% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.46% |
| August 31, 2022 | 94.46% |
| July 31, 2022 | 94.11% |
| June 30, 2022 | 91.11% |
| May 31, 2022 | 91.11% |
| April 30, 2022 | 91.11% |
| March 31, 2022 | 91.11% |
| February 28, 2022 | 91.11% |
| January 31, 2022 | 91.11% |
| December 31, 2021 | 91.11% |
| November 30, 2021 | 91.11% |
| October 31, 2021 | 91.11% |
| September 30, 2021 | 91.11% |
| August 31, 2021 | 91.11% |
| July 31, 2021 | 91.11% |
| June 30, 2021 | 91.11% |
| May 31, 2021 | 91.11% |
| April 30, 2021 | 91.11% |
| March 31, 2021 | 91.11% |
| February 28, 2021 | 91.11% |
| January 31, 2021 | 91.11% |
| December 31, 2020 | 91.11% |
| November 30, 2020 | 91.11% |
| October 31, 2020 | 91.11% |
| September 30, 2020 | 91.11% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.99%
Minimum
Nov 2019
99.47%
Maximum
Nov 2023
93.40%
Average
91.11%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Azenta Inc | 70.61% |
| Perspective Therapeutics Inc | 91.70% |
| Corvus Pharmaceuticals Inc | 95.82% |
| Clearside Biomedical Inc | 95.91% |
| Quanterix Corp | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.32 |
| Beta (5Y) | 0.4955 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.46% |
| Historical Sharpe Ratio (5Y) | -0.5328 |
| Historical Sortino (5Y) | -1.004 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.87% |